There are 2949 resources available
1231P - Significant impact of preoperative smoking period on postoperative prognosis in patients with surgically resected non-small cell lung cancer
Presenter: Shinkichi Takamori
Session: E-Poster Display
Resources:
Abstract
1232P - An exploratory study of a PD-1 inhibitor for high-risk multiple ground-glass nodules (mGGNs) in synchronous stage I non-small cell lung cancer patients
Presenter: Rong Yin
Session: E-Poster Display
Resources:
Abstract
1233P - Epidemiology of female lung cancer in tertiary level hospitals in Bangladesh
Presenter: Abdullah Al Mamun Khan
Session: E-Poster Display
Resources:
Abstract
1234TiP - SYMptom monitoring with patient-reported outcomes using a web application among lung cancer patients in the Netherlands (SYMPRO-Lung)
Presenter: Nicole Billingy
Session: E-Poster Display
Resources:
Abstract
1235TiP - Perioperative pembrolizumab + platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study
Presenter: Masahiro Tsuboi
Session: E-Poster Display
Resources:
Abstract
1238P - Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small cell lung cancer: Results from the ADJUVANT (CTONG1104) study
Presenter: Jian Zeng
Session: E-Poster Display
Resources:
Abstract
1240P - Prognostic impact of the CONtrolling NUTritional status (CONUT) score in patients with stage III non-small cell lung cancer (NSCLC)
Presenter: Vicente Palomar Abril
Session: E-Poster Display
Resources:
Abstract
1241P - Safety monitoring of adjuvant 2 weekly durvalumab for patients with stage III NSCLC: Implications for a 4 weekly regimen during the COVID-19 pandemic and beyond
Presenter: Kroopa Joshi
Session: E-Poster Display
Resources:
Abstract
1242P - Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Presenter: Nicolas Girard
Session: E-Poster Display
Resources:
Abstract
1243P - Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis
Presenter: Nathalie Waser
Session: E-Poster Display
Resources:
Abstract